The Clp Protease System; a Central Component of the Chloroplast Protease Network☆
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
In Silico Signature Prediction Modeling in Cytolethal Distending Toxin-Producing Escherichia Coli Strains
eISSN 2234-0742 Genomics Inform 2017;15(2):69-80 G&I Genomics & Informatics https://doi.org/10.5808/GI.2017.15.2.69 ORIGINAL ARTICLE In Silico Signature Prediction Modeling in Cytolethal Distending Toxin-Producing Escherichia coli Strains Maryam Javadi, Mana Oloomi*, Saeid Bouzari Department of Molecular Biology, Pasteur Institute of Iran, Tehran 13164, Iran In this study, cytolethal distending toxin (CDT) producer isolates genome were compared with genome of pathogenic and commensal Escherichia coli strains. Conserved genomic signatures among different types of CDT producer E. coli strains were assessed. It was shown that they could be used as biomarkers for research purposes and clinical diagnosis by polymerase chain reaction, or in vaccine development. cdt genes and several other genetic biomarkers were identified as signature sequences in CDT producer strains. The identified signatures include several individual phage proteins (holins, nucleases, and terminases, and transferases) and multiple members of different protein families (the lambda family, phage-integrase family, phage-tail tape protein family, putative membrane proteins, regulatory proteins, restriction-modification system proteins, tail fiber-assembly proteins, base plate-assembly proteins, and other prophage tail-related proteins). In this study, a sporadic phylogenic pattern was demonstrated in the CDT-producing strains. In conclusion, conserved signature proteins in a wide range of pathogenic bacterial strains can potentially be used in modern vaccine-design strategies. Keywords: biomarkers, cytolethal distending toxin, genomic signature, multiple alignments, pathogenic Escherichia coli In this study, comparative genome analysis of CDT-pro- Introduction ducer E. coli isolates with other pathogenic and commensal strains was performed. Alignments between multiple The co-evolution of pathogenic bacteria and their hosts genomes led to the identification of a set of distinct leads to the generation of functional pathogen-host inter- (“signature”) sequence motifs. -
(12) United States Patent (10) Patent No.: US 6,395,889 B1 Robison (45) Date of Patent: May 28, 2002
USOO6395889B1 (12) United States Patent (10) Patent No.: US 6,395,889 B1 Robison (45) Date of Patent: May 28, 2002 (54) NUCLEIC ACID MOLECULES ENCODING WO WO-98/56804 A1 * 12/1998 ........... CO7H/21/02 HUMAN PROTEASE HOMOLOGS WO WO-99/0785.0 A1 * 2/1999 ... C12N/15/12 WO WO-99/37660 A1 * 7/1999 ........... CO7H/21/04 (75) Inventor: fish E. Robison, Wilmington, MA OTHER PUBLICATIONS Vazquez, F., et al., 1999, “METH-1, a human ortholog of (73) Assignee: Millennium Pharmaceuticals, Inc., ADAMTS-1, and METH-2 are members of a new family of Cambridge, MA (US) proteins with angio-inhibitory activity', The Journal of c: - 0 Biological Chemistry, vol. 274, No. 33, pp. 23349–23357.* (*) Notice: Subject to any disclaimer, the term of this Descriptors of Protease Classes in Prosite and Pfam Data patent is extended or adjusted under 35 bases. U.S.C. 154(b) by 0 days. * cited by examiner (21) Appl. No.: 09/392, 184 Primary Examiner Ponnathapu Achutamurthy (22) Filed: Sep. 9, 1999 ASSistant Examiner William W. Moore (51) Int. Cl." C12N 15/57; C12N 15/12; (74) Attorney, Agent, or Firm-Alston & Bird LLP C12N 9/64; C12N 15/79 (57) ABSTRACT (52) U.S. Cl. .................... 536/23.2; 536/23.5; 435/69.1; 435/252.3; 435/320.1 The invention relates to polynucleotides encoding newly (58) Field of Search ............................... 536,232,235. identified protease homologs. The invention also relates to 435/6, 226, 69.1, 252.3 the proteases. The invention further relates to methods using s s s/ - - -us the protease polypeptides and polynucleotides as a target for (56) References Cited diagnosis and treatment in protease-mediated disorders. -
Ovarian Dysgenesis and Premature Ovarian Failure (POF)
The Genes Involved in Hearing and Endocrine Disorders A Thesis submitted to the University of Manchester for the degree of Doctor of Philosophy in the Faculty of Medical and Human Sciences. 2012 Emma Mary Jenkinson School of Medicine CONTENTS Content Page List of Tables 7 List of Figures 10 Abstract 16 Declaration 17 Copyright statement 17 Acknowledgment 19 Abbreviations 20 Chapter 1: Introduction 24 1. Introduction 25 1.1. Sensorineural Hearing Loss 25 1.1.1 Genes which Regulate Ion Homeostasis in the Cochlear 28 1.1.2 Genes Responsible for Formation and Maintenance of the 29 Hair bundles 1.1.3 Genes Responsible for Maintenance of the Extracellular 32 Matrix 1.1.4 Transcription Factor Genes 34 1.1.5 Genes of Poorly Established Function 35 1.1.6 The Need for Further Research in Deafness Genetics 37 1.2 Hypothalamic Pituitary Gonadal axis 37 1.2.1 Hypogonadotropic Hypogonadism 39 1.2.2 Hypergonadotropic Hypogonadism: Premature Ovarian 52 Failure (POF) and Ovarian Dysgenesis 1.2.3 Premature Ovarian Failure and Sensorineural Hearing 71 Loss: Perrault Syndrome 1.3 The Evolution of Techniques in Genetic Medicine 80 1.3.1 Linkage Mapping 80 1.3.2 From Locus to Gene Mutation 83 1.3.3 Next Generation Sequencing 84 1.4 Aim 89 Chapter 2: Materials and Methods 91 2.Materials and Methods 92 2 2.1 Suppliers 92 2.2 Nucleic Acid procedures 92 2.2.1 DNA Extraction 92 2.2.2 RNA Extraction 92 2.2.3 Quantification of Nucleic Acids 93 2.2.4 Standard PCR Reaction 93 2.2.5 Agarose Gel Electrophoresis 94 2.2.6 Purification of PCR Products 95 2.2.7 Sequencing -
Serine Proteases with Altered Sensitivity to Activity-Modulating
(19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants. -
Next Generation Sequencing Identifies Five Major Classes of Potentially Therapeutic Enzymes Secreted by Lucilia Sericata Medical Maggots
Hindawi Publishing Corporation BioMed Research International Volume 2016, Article ID 8285428, 27 pages http://dx.doi.org/10.1155/2016/8285428 Research Article Next Generation Sequencing Identifies Five Major Classes of Potentially Therapeutic Enzymes Secreted by Lucilia sericata Medical Maggots Zdenjk Franta,1 Heiko Vogel,2 Rüdiger Lehmann,1 Oliver Rupp,3 Alexander Goesmann,3 and Andreas Vilcinskas1,4 1 Department of Bioresources, Fraunhofer Institute for Molecular Biology and Applied Ecology, Winchesterstraße 2, 35394 Giessen, Germany 2Department of Entomology, Max Planck Institute for Chemical Ecology, Hans-Knoll-Straße¨ 8, 07745 Jena, Germany 3Justus-Liebig-University of Giessen, Bioinformatics and System Biology, Heinrich-Buff-Ring 58, 35392 Giessen, Germany 4Justus-Liebig-University of Giessen, Institute for Insect Biotechnology, Heinrich-Buff-Ring 26-32, 35392 Giessen, Germany Correspondence should be addressed to Andreas Vilcinskas; [email protected] Received 29 January 2016; Accepted 7 March 2016 Academic Editor: Yudong Cai Copyright © 2016 Zdenekˇ Franta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Lucilia sericata larvae are used as an alternative treatment for recalcitrant and chronic wounds. Their excretions/secretions contain molecules that facilitate tissue debridement, disinfect, or accelerate wound healing and have therefore -
Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases
Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases Alan J. Barrett Neil D. Rawlings J. Fred Woessner Editor biographies xxi Contributors xxiii Preface xxxi Introduction ' Abbreviations xxxvii ASPARTIC PEPTIDASES Introduction 1 Aspartic peptidases and their clans 3 2 Catalytic pathway of aspartic peptidases 12 Clan AA Family Al 3 Pepsin A 19 4 Pepsin B 28 5 Chymosin 29 6 Cathepsin E 33 7 Gastricsin 38 8 Cathepsin D 43 9 Napsin A 52 10 Renin 54 11 Mouse submandibular renin 62 12 Memapsin 1 64 13 Memapsin 2 66 14 Plasmepsins 70 15 Plasmepsin II 73 16 Tick heme-binding aspartic proteinase 76 17 Phytepsin 77 18 Nepenthesin 85 19 Saccharopepsin 87 20 Neurosporapepsin 90 21 Acrocylindropepsin 9 1 22 Aspergillopepsin I 92 23 Penicillopepsin 99 24 Endothiapepsin 104 25 Rhizopuspepsin 108 26 Mucorpepsin 11 1 27 Polyporopepsin 113 28 Candidapepsin 115 29 Candiparapsin 120 30 Canditropsin 123 31 Syncephapepsin 125 32 Barrierpepsin 126 33 Yapsin 1 128 34 Yapsin 2 132 35 Yapsin A 133 36 Pregnancy-associated glycoproteins 135 37 Pepsin F 137 38 Rhodotorulapepsin 139 39 Cladosporopepsin 140 40 Pycnoporopepsin 141 Family A2 and others 41 Human immunodeficiency virus 1 retropepsin 144 42 Human immunodeficiency virus 2 retropepsin 154 43 Simian immunodeficiency virus retropepsin 158 44 Equine infectious anemia virus retropepsin 160 45 Rous sarcoma virus retropepsin and avian myeloblastosis virus retropepsin 163 46 Human T-cell leukemia virus type I (HTLV-I) retropepsin 166 47 Bovine leukemia virus retropepsin 169 48 -
203-212 203 Overview and Perspectives on the Transcriptome of Paracoccidioides Brasiliensis
Review Rev Iberoam Micol 2005; 22: 203-212 203 Overview and perspectives on the transcriptome of Paracoccidioides brasiliensis Rosângela V. Andrade1, Silvana P. da Silva2, Fernando A. G. Torres1, Marcio José Poças-Fonseca1, Ildinete Silva-Pereira1, Andrea Q. Maranhão1, Élida G. Campos1, Lídia Maria P. Moraes1, Rosália S. A. Jesuíno3, Maristela Pereira3, Célia M. A. Soares3, Maria Emília M. T. Walter1, Maria José A. Carvalho1, Nalvo F. Almeida4, Marcelo M. Brígido1 and Maria Sueli S. Felipe1 1Departamento de Biologia Celular, Universidade de Brasília, Brasília; 2Departamento de Bioquímica, Universidade Estadual de Londrina, Londrina; 3Departamento de Bioquímica, Universidade Federal de Goiás, Goiânia; 4Departamento de Computação e Estatística, Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil Summary Paracoccidioides brasiliensis is a dimorphic and thermo-regulated fungus which is the causative agent of paracoccidioidomycosis, an endemic disease widespre- ad in Latin America that affects 10 million individuals. Pathogenicity is assumed to be a consequence of the dimorphic transition from mycelium to yeast cells during human infection. This review shows the results of the P. brasiliensis trans- criptome project which generated 6,022 assembled groups from mycelium and yeast phases. Computer analysis using the tools of bioinformatics revealed seve- ral aspects from the transcriptome of this pathogen such as: general and diffe- rential metabolism in mycelium and yeast cells; cell cycle, DNA replication, repair and recombination; RNA biogenesis apparatus; translation and protein fate machineries; cell wall; hydrolytic enzymes; proteases; GPI-anchored proteins; molecular chaperones; insights into drug resistance and transporters; oxidative stress response and virulence. The present analysis has provided a more com- prehensive view of some specific features considered relevant for the understan- ding of basic and applied knowledge of P. -
Geobacillus Lituanicus DSM 15325T Kolagenolizinės Peptidazės U32.002 Geno Transkripcijos Analizė Bei Klonavimas
VILNIAUS UNIVERSITETAS GAMTOS MOKSLŲ FAKULTETAS MIKROBIOLOGIJOS IR BIOTECHNOLOGIJOS KATEDRA Mikrobiologijos studijų programos magistrantas Andrius JASILIONIS Magistrinis darbas Geobacillus lituanicus DSM 15325T kolagenolizinės peptidazės U32.002 geno transkripcijos analizė bei klonavimas Darbo vadovė: dr. Nomeda KUISIENĖ Vilnius 2011 Geobacillus lituanicus DSM 15325T kolagenolizinės peptidazės U32.002 geno transkripcijos analizė bei klonavimas Darbas atliktas Vilniaus universiteto Gamtos mokslų fakulteto Mikrobiologijos ir biotechnologijos katedroje Andrius JASILIONIS Darbo vadovė: Nomeda KUISIENĖ 2 TURINYS SANTRUMPŲ SĄRAŠAS // 4 ĮVADAS // 5 1. LITERATŪROS APŢVALGA 1.1 Kolagenai - kolagenolizės substratai // 6 1.2 Kolagenolizinės peptidazės // 10 1.2.1 Eukariotų kolagenoliziniai fermentai // 13 1.2.2 Prokariotų kolagenoliziniai fermentai // 15 1.2.2.1 U32 kolagenolizinių peptidazių šeima // 18 1.3 Kolagenolizė: bendrasis modelis // 23 1.4 Praktinė kolagenolizės svarba // 24 2. METODAI 2.1 Tirti kamienai // 26 2.2. Medţiagos 2.2.1 Medţiagos terpių ir buferių gamybai // 26 2.2.2 Komerciniai rinkiniai // 26 2.2.3 Medţiagos PGR ir nukleorūgščių vizualizavimui // 26 2.2.4 Kitos medţiagos // 27 2.3. Terpės 2.3.1 Terpės biomasės prieaugiui, palaikymui ir kultūros grynumo patikrinimui // 27 2.3.2 Skysta terpė kamieno kultivavimui vykdant transkripcijos analizę // 27 2.4 Metodai 2.4.1 Kultūros grynumo patikrinimas // 28 2.4.2 Suminės RNR preparatų iš G. lituanicus DSM 15325T išskyrimas // 28 2.4.3 kDNR sintezė // 29 2.4.4 U32.002 kolagenolizinės -
2007 Ciências Básicas Moleculares
XV Congresso de Iniciação Científica da UNIFESP – 2007 Ciências Básicas Moleculares UNIVERSIDADE FEDERAL DE SÃO PAULO ESCOLA PAULISTA DE MEDICINA XV CONGRESSO DE INICIAÇÃO CIENTÍFICA REITOR Prof. Dr. Ulysses Fagundes Neto VICE-REITOR Prof. Dr. Sergio Tufik PRÓ-REITORIAS Graduação Prof. Dr. Luiz Eugênio Araújo de Moraes Mello Pós-Graduação e Pesquisa Prof. Dr. Nestor Schor Extensão Prof. Dr. Walter Manna Albertoni Administração Prof. Dr. Sérgio Antonio Draibe 1 XV Congresso de Iniciação Científica da UNIFESP – 2007 Ciências Básicas Moleculares COMISSÃO ORGANIZADORA COORDENAÇÃO DO PIBIC - CONGRESSO Profa. Dra. Helena Bonciani Nader Profa. Dra. Lucia de Oliveira Sampaio Prof. Dr. Luiz Eugênio Araújo de Moraes Mello COMISSÃO INSTITUCIONAL DE INICIAÇÃO CIENTÍFICA Comitê Institucional Profa. Dra. Adriana Karaoglanovic Carmona Prof. Dr. Angelo Amato Vincenzo de Paola Profa. Dra. Anita Hilda Straus Takahashi Profa. Dra. Brasília Maria Chiari Profa. Dra. Clara Lucia Barbieri Mestriner Profa. Dra. Clara Regina Brandão de Ávila Profa. Dra. Eliane Beraldi Ribeiro Profa. Dra. Emília Inoue Sato Profa. Dra. Heimar de Fátima Marin Profa. Dra. Ieda Maria Longo Maugeri Profa. Dra. Janete Maria Cerutti Profa. Dra. Janine Schirmer Prof. Dr. José Carlos Costa Baptista Silva Prof. Dr. José Maria Soares Júnior Prof. Dr. Luiz Roberto Ramos Prof. Dr. Manuel de Jesus Simões Profa. Dra. Mara Helena de Andréa Gomes Profa. Dra. Maria Gerbase de Lima Profa. Dra. Marília de Arruda Cardoso Smith Profa. Dra. Neusa Pereira da Silva Prof. Dr. Reynaldo Jesus Garcia Filho Prof. Dr. Roberto Frussa Filho Profa. Dra. Rosana Fiorini Puccini Prof. Dr. Sang Won Han Profa. Dra. Sima Godosevicius Katz Comitê Externo Prof. Dr. Eder Carlos Rocha Quintão Prof. -
(12) Patent Application Publication (10) Pub. No.: US 2004/0081648A1 Afeyan Et Al
US 2004.008 1648A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0081648A1 Afeyan et al. (43) Pub. Date: Apr. 29, 2004 (54) ADZYMES AND USES THEREOF Publication Classification (76) Inventors: Noubar B. Afeyan, Lexington, MA (51) Int. Cl." ............................. A61K 38/48; C12N 9/64 (US); Frank D. Lee, Chestnut Hill, MA (52) U.S. Cl. ......................................... 424/94.63; 435/226 (US); Gordon G. Wong, Brookline, MA (US); Ruchira Das Gupta, Auburndale, MA (US); Brian Baynes, (57) ABSTRACT Somerville, MA (US) Disclosed is a family of novel protein constructs, useful as Correspondence Address: drugs and for other purposes, termed “adzymes, comprising ROPES & GRAY LLP an address moiety and a catalytic domain. In Some types of disclosed adzymes, the address binds with a binding site on ONE INTERNATIONAL PLACE or in functional proximity to a targeted biomolecule, e.g., an BOSTON, MA 02110-2624 (US) extracellular targeted biomolecule, and is disposed adjacent (21) Appl. No.: 10/650,592 the catalytic domain So that its affinity Serves to confer a new Specificity to the catalytic domain by increasing the effective (22) Filed: Aug. 27, 2003 local concentration of the target in the vicinity of the catalytic domain. The present invention also provides phar Related U.S. Application Data maceutical compositions comprising these adzymes, meth ods of making adzymes, DNA's encoding adzymes or parts (60) Provisional application No. 60/406,517, filed on Aug. thereof, and methods of using adzymes, Such as for treating 27, 2002. Provisional application No. 60/423,754, human Subjects Suffering from a disease, Such as a disease filed on Nov. -
Alterations in Gene Expression of Renin-Angiotensin System Components and Related Proteins in Colorectal Cancer
Hindawi Journal of the Renin-Angiotensin-Aldosterone System Volume 2021, Article ID 9987115, 17 pages https://doi.org/10.1155/2021/9987115 Research Article Alterations in Gene Expression of Renin-Angiotensin System Components and Related Proteins in Colorectal Cancer Danial Mehranfard ,1 Gabriela Perez,2 Andres Rodriguez,3 Julia M. Ladna,4 Christopher T. Neagra,5 Benjamin Goldstein,6 Timothy Carroll,7 Alice Tran,8 Malav Trivedi,1 and Robert C. Speth 1 1College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, USA 2Department of Internal Medicine, Palmetto General Hospital, Hialeah, FL, USA 3Department of Internal Medicine, University of Miami/Jackson Memorial Hospital, Miami, FL, USA 4Broward Health Medical Center, Fort Lauderdale, FL, USA 5Baylor College of Medicine, Houston, TX, USA 6University of Florida, Gainesville, FL, USA 7College of Psychology, Nova Southeastern University, Fort Lauderdale, FL, USA 8Halmos College of Arts and Sciences, Nova Southeastern University, Fort Lauderdale, FL, USA Correspondence should be addressed to Robert C. Speth; [email protected] Received 2 February 2021; Revised 13 May 2021; Accepted 7 June 2021; Published 6 July 2021 Academic Editor: Peter Sever Copyright © 2021 Danial Mehranfard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Hypothesis/Introduction. Recent studies suggest involvement of the renin-angiotensin system (RAS) in cancers, including colorectal cancer (CRC). This study focuses on the association of genes encoding 17 proteins related to the RAS within a Japanese male CRC population. Materials and Methods. Quantitative expression of the RNA of these 17 genes in normal and cancerous tissues obtained using chip arrays from the public functional genomics data repository, Gene Expression Omnibus (GEO) application, was compared statistically. -
Assembly of Bacteriophage 80Α Capsids in a Staphylococcus Aureus
Virology 434 (2012) 242–250 Contents lists available at SciVerse ScienceDirect Virology journal homepage: www.elsevier.com/locate/yviro Assembly of bacteriophage 80a capsids in a Staphylococcus aureus expression system Michael S. Spilman a,1,2, Priyadarshan K. Damle b,1, Altaira D. Dearborn a,1, Cynthia M. Rodenburg a, Jenny R. Chang a,3, Erin A. Wall b, Gail E. Christie b, Terje Dokland a,n a Department of Microbiology, University of Alabama at Birmingham, 845, 19th St South, BBRB 311, Birmingham, AL 35294, USA b Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA 23298, USA article info abstract Available online 12 September 2012 80a is a temperate, double-stranded DNA bacteriophage of Staphylococcus aureus that can act as a Keywords: ‘‘helper’’ for the mobilization of S. aureus pathogenicity islands (SaPIs), including SaPI1. When SaPI1 is Molecular piracy mobilized by 80a, the SaPI genomes are packaged into capsids that are composed of phage proteins, but Virus assembly that are smaller than those normally formed by the phage. This size determination is dependent on Size determination SaPI1 proteins CpmA and CpmB. Here, we show that co-expression of the 80a capsid and scaffolding Procapsid proteins in S. aureus, but not in E. coli, leads to the formation of procapsid-related structures, suggesting Electron microscopy that a host co-factor is required for assembly. The capsid and scaffolding proteins also undergo normal Scaffolding protein N-terminal processing upon expression in S. aureus, implicating a host protease. We also find that SaPI1 Ribosomal protein L27 proteins CpmA and CpmB promote the formation of small capsids upon co-expression with 80a capsid Co-expression and scaffolding proteins in S.